RxDoctor Payments Data

Megan Hopps, APRN

Nurse Practitioner · Sherman, ILNPI 1679119226

Payments from drug & device makers

$596in general payments, 2019–2025

Across 35 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$96
  • Lilly USA, LLC$77
  • Pfizer$52
  • Novo Nordisk$44
  • Xeris Pharmaceuticals, Inc.$41
  • Phathom Pharmaceuticals, Inc.$41
  • plus $245 from 11 others

What the payments were for

  • Food & beverage$596100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$596 in reported general payments places this provider in the 75th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$84,301
Medicare patients
240
Services billed
1,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$68,498
MounjaroTirzepatide50$49,974
FarxigaDapagliflozin Propanediol43$44,503
OzempicSemaglutide30$40,755
RytaryCarbidopa/Levodopa11$15,990
RybelsusSemaglutide13$15,320
XareltoRivaroxaban19$14,137
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,660
Humalog Kwikpen U-200Insulin Lispro11$7,588
SymbicortBudesonide/Formoterol Fumarate12$2,833
Atorvastatin Calcium380$2,658
Levothyroxine Sodium309$2,338
Metoprolol Succinate195$2,104
Pantoprazole Sodium146$1,996
Losartan Potassium182$1,973

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$52$68,49879 claims
Novo NordiskOzempic, Rybelsus$44$56,07543 claims
Lilly USA, LLCMounjaro$77$49,97450 claims
AstraZenecaFarxiga, Symbicort$96$47,33655 claims
Johnson & JohnsonXarelto$13$14,13719 claims
Almatica Pharma LLCSertraline Hcl$27$804131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Sherman

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →